The year 2024 in the substance use disorder (SUD) treatment industry has been a dynamic mix of formidable challenges, technological disruptions, and unexpected breakthroughs....
In recent years, mergers and acquisitions (M&A) within the substance use disorder (SUD) treatment space have been relatively slow. However, with the anticipated shift...
Weight-loss medications like Ozempic and Wegovy, which were originally developed for the treatment of diabetes, have become a sensation in recent years as effective...
Pelago, a trailblazer in virtual substance use management, has recently announced the appointment of Frank Jennings as its new president. With an impressive background...
Medication-assisted treatment (MAT) has long been recognized as the gold standard in treating opioid use disorder (OUD). Medications such as methadone and buprenorphine, both...
In a groundbreaking move for the digital health space, Jimini, an AI-backed therapy platform, has secured $8 million in pre-seed funding. The New York-based...